Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1983 Apr;15(1):1–10. doi: 10.1007/BF00199454

Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization

Amitabha Mazumder 1,✉, Elizabeth A Grimm 1, Steven A Rosenberg 1
PMCID: PMC11039249  PMID: 6603260

Abstract

We have previously demonstrated that cancer patients' peripheral blood lymphocytes (PBL) allosensitized against single or pool normal donor PBL are capable of lysing fresh autologous tumor cells in a 4-h 51Cr-release assay. In this report, we present further investigations into this phenomenon. These alloactivated killer cells (A-AK cells) lysed autologous and allogeneic tumors and allogeneic but not autologous PBL. Furthermore, cold target inhibition studies demonstrated that autologous and allogeneic tumors were lysed by the same effector cells. Multiple metastases from the same patient were equivalently lysed by these A-AK cells. The presence of adherent cells and proliferation of the precursors were necessary to generate A-AK cells, although the effector cell itself was radioresistant and nonadherent. The effects of allosensitization were enhanced by the addition of lectin-free interleukin-2 preparations to the in vitro culture by partial depletion of adherent cells prior to sensitization. The A-AK effector cell was OKT3+, OKT8+, OKT4−, OKM1− and could be generated by just 3 days of allosensitization. The precursors for A-AK cells could be separated from NK cells on percoll gradients and lysis could be generated from thoracic duct lymphocytes, a population devoid of NK cells. The phenotype of the majority of the precursor cells was OKT3+, OKT4−. These allocatived PBL could be expanded in crude or lectin-free interleukin-2 without loss of cytotoxicity for fresh autologous tumor cells. Activated T cells represent a population of non-NK cells with broad lytic specificity for fresh tumor cells. Such cells may be of value in the adoptive immunotherapy of human solid tumors and may play a role in immune surveillance.

Keywords: Effector Cell, Peripheral Blood Lymphocyte, Thoracic Duct, Adoptive Immunotherapy, Human Solid Tumor

References

  • 1.Bakaes T, Gergely P, Klein E. Characterization of cytotoxic human T lymphocyte subpopulations: This role of Fc receptor carrying cells. Cell Immunol. 1974;36:317. doi: 10.1016/0008-8749(77)90208-8. [DOI] [PubMed] [Google Scholar]
  • 2.Bolhuis RL, Shunt ARE, Nooy AM, Ronteltap CPM. Characterization of natural killer (NK) and killer (K) cells in human blood: Discrimination between NK and K cell activities. Eur J Immunol. 1976;8:731. doi: 10.1002/eji.1830081012. [DOI] [PubMed] [Google Scholar]
  • 3.Breard J, Reinherz EL, Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol. 1980;124:1943. [PubMed] [Google Scholar]
  • 4.Cytopathology Section, NCI, NIH, DHEW (1974) Cytopathology handbook, 7th revision, p 42
  • 5.Enberg RM, Eberle JJ, Williams RC. T and B cells in peripheral blood during infectious mononucleosis. J Infect Dis. 1974;130:104. doi: 10.1093/infdis/130.2.104. [DOI] [PubMed] [Google Scholar]
  • 6.Fidler IJ, Gersten DM, Budmen MB. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res. 1976;36:3160. [PubMed] [Google Scholar]
  • 7.Fogel M, Gorelik E, Segal E, Feldman M. Differences in cell surface antigens of tumor metastases and those of local tumor. J Natl Cancer Inst. 1979;62:585. doi: 10.1093/jnci/62.3.585. [DOI] [PubMed] [Google Scholar]
  • 8.Forbes JT, Niblack GD, Fuchs R, Richie RE, Johnson HK, Oldham RK. Human natural cell-mediated cytotoxicity. I. Levels in peripheral blood, cord blood and thoracic duct. Cancer Immunol Immunother. 1981;11:139. [Google Scholar]
  • 9.Golub SH. In vitro sensitization of human lymphoid cells to antigens on cultured melanoma cells. II. Sensitization against melanoma-associated antigens. Cell Immunol. 1977;28:379. doi: 10.1016/0008-8749(77)90120-4. [DOI] [PubMed] [Google Scholar]
  • 10.Golub SH, Golightly MG, Zielske JV. ‘NK-like’ cytotoxicity of human lymphocytes cultured in medium containing fetal bovine serum. Int J Cancer. 1979;24:273. doi: 10.1002/ijc.2910240302. [DOI] [PubMed] [Google Scholar]
  • 11.Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. The lymphokine-activated killer cell phenomenon: Lysis of NK resistant fresh solid tumor cells by IL-2 activated autologous human peripheral blood lymphocytes. J Exp Med. 1982;155:1823. doi: 10.1084/jem.155.6.1823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Grimm EA, Mazumder A, Rosenberg SA (to be published) Augmentation of human in vitro sensitization with partially purified TCGF. Cell Immunol [DOI] [PubMed]
  • 13.Julius MH, Simpson E, Herzenberg LA. A rapid method for the isolation of functional thymus derived murine lymphocytes. Eur J Immunol. 1973;3:645. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  • 14.Kedar E, Ikejiri BL, Bonnard GD, Herberman R (to be published) A rapid method for isolation of viable tumor cells from solid tumors: Use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses. J Immunol Methods [DOI] [PubMed]
  • 15.Klein E, Vanky F. Natural and activated cytotoxic lymphocytes which act on autologous and allogeneic tumor cells. Cancer Immunol Immunother. 1981;11:183. [Google Scholar]
  • 16.Kobayashi H, Hoshokova M, Oikawa T. Transplantation immunity to syngeneic tumors in WKR rats immunized with allogeneic cells. Transplant Proc. 1980;12:156. [PubMed] [Google Scholar]
  • 17.Koide YS, Takasugi M. Augmentation of human natural cell-mediated cytotoxicity by a soluble factor. I. Production of N-cell-activating factor (NAF) J Immunol. 1978;121:872. [PubMed] [Google Scholar]
  • 18.Kung PC, Goldstein G, Reinherz EL, Schlossman S. Monoclonal antibody defining distinctive human T-cell surface antigen. Science. 1979;206:349. [PubMed] [Google Scholar]
  • 19.Larsson EL. Mechanisms of T cell activation. II. Antigen and lectin-dependent acquisition of responsiveness to TCGF is a non-mitogenic, active response of resting T cells. J Immunol. 1981;126:1323. [PubMed] [Google Scholar]
  • 20.Lotze MT, Rosenberg SA. The preparation of lectin-free TCGF and an analysis of its activity. J Immunol. 1981;126:2215. [PubMed] [Google Scholar]
  • 21.Martin-Chandon MR, Vanby F, Carnand C, Klein E. In vitro “education” on autologous human sarcoma generates non-specific killer cells. Int J Cancer. 1975;15:342. doi: 10.1002/ijc.2910150218. [DOI] [PubMed] [Google Scholar]
  • 22.Masucci MG, Klein E, Argov S. Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures. J Immunol. 1980;124:2458. [PubMed] [Google Scholar]
  • 23.Mazumder A, Grimm EA, Zhang HZ, Rosenberg SA. Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins. Cancer Res. 1982;42:913. [PubMed] [Google Scholar]
  • 24.McAlack RF. Normal HLA phenotypes and neo-HLA-like antigens on cultured human neuroblastoma. Transplant Proc. 1980;12:107. [PubMed] [Google Scholar]
  • 25.Mukherji B, Flowers A, Rothman L, Nathanson L. Spontaneous in vitro cytotoxicity against autochthonous human melanoma cells. J Immunol. 1980;124:412. [PubMed] [Google Scholar]
  • 26.Okada M, Yoshimura N, Kaieda T, Yamamura Y, Kishimoto T. Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. Proc Natl Acad Sci USA. 1981;78:7717. doi: 10.1073/pnas.78.12.7717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ortaldo JR, Sharrow SO, Timonen T, Herberman RB. Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol. 1981;127:2401. [PubMed] [Google Scholar]
  • 28.Paciucci PA, MacPhail S, Bach FH, Zarling J. Requirement for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells. J Immunol. 1980;125:36. [PubMed] [Google Scholar]
  • 29.Pellegrino MA, Ferrone S, Broutbar C, Hayflick L. Changes in HLA antigen profiles on SV-40 transformed human fibroblasts. Exp Cell Res. 1976;97:340. doi: 10.1016/0014-4827(76)90625-x. [DOI] [PubMed] [Google Scholar]
  • 30.Poros A, Klein E. Culture with K562 leads to blastogenesis and increased cytotoxicity with changed properties of active cells when compared to fresh lymphocytes. Cell Immunol. 1979;41:240. doi: 10.1016/0008-8749(78)90222-8. [DOI] [PubMed] [Google Scholar]
  • 31.Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Further characterization of the human inducer T cells subset defined by a monoclonal antibody. J Immunol. 1979;123:2894. [PubMed] [Google Scholar]
  • 32.Seeley JK, Golub SH. Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities. J Immunol. 1978;124:2458. [PubMed] [Google Scholar]
  • 33.Sharma B, Odom LF. Generation of killer lymphocytes in vitro against human autologous leukemia cells with leukemic blasts and BCG extract. Cancer Immunol Immunother. 1979;7:99. [Google Scholar]
  • 34.Sharma B, Terasaki PI. In vitro immunization to cultured human tumor cells. Cancer Res. 1974;34:115. [PubMed] [Google Scholar]
  • 35.Shaw S, Nelson DL, Shearer GM. Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. I. T cell recognition of TNP in association with widely shared antigens. J Immunol. 1978;121:281. [PubMed] [Google Scholar]
  • 36.Singh JN, Sabbadini E, Sehon AH. Detection of unspecific cytotoxicity in grafts-versus-host reaction as a function of target cell type. Cell Immunol. 1973;8:280. doi: 10.1016/0008-8749(73)90117-2. [DOI] [PubMed] [Google Scholar]
  • 37.Sone S, Fidler IJ. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes. Cell Immunol. 1980;57:42. doi: 10.1016/0008-8749(81)90118-0. [DOI] [PubMed] [Google Scholar]
  • 38.Stejskal V, Holm G, Perlmann P. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. I. Activation by tuberculin and staphylococcus filtrate. Cell Immunol. 1973;8:71. doi: 10.1016/0008-8749(73)90094-4. [DOI] [PubMed] [Google Scholar]
  • 39.Strausser HL, Rosenberg SA. In vitro growth of cytotoxic human lymphocytes. I. Growth of cells sensitized in vitro to alloantigens. J Immunol. 1978;121:1491. [PubMed] [Google Scholar]
  • 40.Strausser JL, Mazumder A, Grimm EA, Lotze MT, Rosenberg SA. Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens. J Immunol. 1981;127:266. [PubMed] [Google Scholar]
  • 41.Sugarbaker EV, Cohen AM. Altered antigenicity in spontaneous pulmonary metastases from an antigenic murine sarcoma. Surgery. 1972;72:1972. [PubMed] [Google Scholar]
  • 42.Suthanthiram M, Rubin AL, Novogrodsky A, Stenzel KH. Biological effects of activation of peripheral blood mononuclear cells by mitogenic oxidizing agents. Cell Immunol. 1981;59:26. doi: 10.1016/0008-8749(81)90431-7. [DOI] [PubMed] [Google Scholar]
  • 43.Svedmyr EA, Jondal M. Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infections mononucleosis. Proc. Natl Acad Sci USA. 1975;72:1622. doi: 10.1073/pnas.72.4.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Timonen T, Saksela E. Isolation of human NK cells by density gradient centrifugation. J Immunol Methods. 1980;36:285. doi: 10.1016/0022-1759(80)90133-7. [DOI] [PubMed] [Google Scholar]
  • 45.Treves AJ, Heidelberger E, Feldman M, Kaplan HA. In vitro sensitization of human lymphocytes against histocytolymphoma lines. II. Characterization of two different effector activities and of suppressor cells. J Immunol. 1978;121:86. [PubMed] [Google Scholar]
  • 46.Vanky FT, Argov SM, Einhorn SA, Klein E. Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive to interferon-induced cytotoxicity of human blood lymphocytes. J Exp Med. 1980;151:1151. doi: 10.1084/jem.151.5.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Vanky F, Gorsky T, Gorsky Y, Masucci MG, Klein E. Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor. J Exp Med. 1982;155:83. doi: 10.1084/jem.155.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Zarling JM, Robins HI, Raich PC, Bach FH, Bach ML. Generation of cytotoxic T lymphocytes to human leukemia cells by sensitization to pooled allogeneic normal cells. Nature. 1978;274:269. doi: 10.1038/274269a0. [DOI] [PubMed] [Google Scholar]
  • 49.Zarling JM, Bach FH, Kung PC. Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines. J Immunol. 1981;126:375. [PubMed] [Google Scholar]
  • 50.Zielske JV, Golub SH. Fetal calf serum-induced blastogenic and cytotoxic response of human lymphocytes. Cancer Res. 1976;36:3842. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES